Missouri-based pharma Nostrum Laboratories and its CEO have agreed to pay a minimum $3.8 million and up to $50 million to settle accusations from the US Department of Justice that the company violated the False Claims Act.
Nostrum's Generic Venlafaxine Hydrochloride Receives Approval in the U.S.
Enforcement Report - Week of February 10, 2021
Enforcement Report - Week of January 20, 2021
Nostrum Laboratories, Inc. Expands Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets
Generic metformin has been a thorn in drugmakers’ sides for months after a probable human carcinogen was found in tested lots. Now, one of the companies is expanding its recall to another lot of the drug.
Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg
Associated Press (AP) recently analyzed and published data regarding brand-name prescription drug prices. This was largely in response to President Donald Trump’s promises during the presidential campaign and in a May policy announcement that he would drive down drug prices. In fact, at the end of May, Trump promised pharma companies would be announcing “massive” voluntary drug prices within two weeks.
Enforcement Report - Week of February 28, 2018